Sinopharm
1099.HK
#2278
Rank
โ‚น757.88 B
Marketcap
โ‚น242.86
Share price
0.87%
Change (1 day)
12.63%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.242 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.242 Trillion. In 2024 the company made a revenue of โ‚น7.242 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.632 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.242 T-5.1%
2023โ‚น7.632 T5.42%
2022โ‚น7.239 T-2.1%
2021โ‚น7.394 T16.85%
2020โ‚น6.328 T14.95%
2019โ‚น5.505 T21.52%
2018โ‚น4.530 T5.93%
2017โ‚น4.276 T27.22%
2016โ‚น3.361 T5.37%
2015โ‚น3.190 T9.14%
2014โ‚น2.922 T17.22%
2013โ‚น2.493 T25.94%
2012โ‚น1.979 T34.61%
2011โ‚น1.470 T55.34%
2010โ‚น946.86 B35.79%
2009โ‚น697.31 B37.56%
2008โ‚น506.92 B31.43%
2007โ‚น385.71 B40.26%
2006โ‚น274.99 B